Yongyin Li

1.3k total citations
40 papers, 918 citations indexed

About

Yongyin Li is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Yongyin Li has authored 40 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 21 papers in Immunology and 17 papers in Hepatology. Recurrent topics in Yongyin Li's work include Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (10 papers). Yongyin Li is often cited by papers focused on Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (10 papers). Yongyin Li collaborates with scholars based in China, New Zealand and United Kingdom. Yongyin Li's co-authors include Yingsong Wu, Libo Tang, Xiang-Ming Zhai, Hui Zhao, Lun Bian, Lin Li, Peng Li, Zhenhua Chen, Lei Yu and Zhigao Zhang and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and The Journal of Infectious Diseases.

In The Last Decade

Yongyin Li

37 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongyin Li China 14 388 294 262 242 214 40 918
Jingying Zhou China 16 220 0.6× 62 0.2× 303 1.2× 92 0.4× 308 1.4× 51 1.0k
William Wan United States 18 284 0.7× 169 0.6× 377 1.4× 670 2.8× 62 0.3× 23 1.5k
Jacqueline K. Flynn Australia 15 230 0.6× 29 0.1× 166 0.6× 278 1.1× 336 1.6× 28 945
Amr S. Khaled United States 14 102 0.3× 38 0.1× 211 0.8× 250 1.0× 141 0.7× 24 1.0k
Kiera Clayton United States 15 494 1.3× 67 0.2× 265 1.0× 127 0.5× 605 2.8× 25 1.3k
Veronica Bordoni Italy 19 178 0.5× 30 0.1× 225 0.9× 139 0.6× 369 1.7× 56 884
Rachel Latanich United States 12 81 0.2× 44 0.1× 238 0.9× 376 1.6× 158 0.7× 17 872
Christian Schütz Germany 12 44 0.1× 96 0.3× 175 0.7× 181 0.7× 467 2.2× 22 833
Sian Llewellyn‐Lacey United Kingdom 17 170 0.4× 36 0.1× 219 0.8× 561 2.3× 876 4.1× 33 1.3k
Sisse B. Ditlev Denmark 19 58 0.1× 40 0.1× 256 1.0× 112 0.5× 468 2.2× 38 1.1k

Countries citing papers authored by Yongyin Li

Since Specialization
Citations

This map shows the geographic impact of Yongyin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongyin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongyin Li more than expected).

Fields of papers citing papers by Yongyin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongyin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongyin Li. The network helps show where Yongyin Li may publish in the future.

Co-authorship network of co-authors of Yongyin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yongyin Li. A scholar is included among the top collaborators of Yongyin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongyin Li. Yongyin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chengcong, Yongjun Zhou, Libo Tang, et al.. (2024). Anti-HBc mirrors the activation of HBV-specific CD8+ T cell immune response and exhibits a direct effect on HBV control. Antiviral Research. 230. 105975–105975. 1 indexed citations
2.
Xu, Hong‐Xi, Yongyin Li, Qiongqiong Wang, et al.. (2023). Alcohol reshapes a liver premetastatic niche for cancer by extra- and intrahepatic crosstalk-mediated immune evasion. Molecular Therapy. 31(9). 2662–2680. 17 indexed citations
3.
Zhou, Yang, et al.. (2023). CTLA4+CD4+CXCR5−FOXP3+ T cells associate with unfavorable outcome in patients with chronic HBV infection. BMC Immunology. 24(1). 3–3. 8 indexed citations
4.
Zhou, Yang, Yongjun Zhou, Shuqin Gu, et al.. (2023). HBV Core-specific CD4+ T cells correlate with sustained viral control upon off-treatment in HBeAg-positive chronic hepatitis B patients. Antiviral Research. 213. 105585–105585. 4 indexed citations
5.
Liu, Zhenguo, Junling Chen, Yongjun Zhou, et al.. (2023). Causal associations between chronic hepatitis B and COVID-19 in East Asian populations. Virology Journal. 20(1). 109–109. 2 indexed citations
7.
Zhang, Panli, Peng Zou, Jinfeng Li, et al.. (2022). Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2. Molecular Therapy — Methods & Clinical Development. 26. 181–190. 1 indexed citations
8.
Liu, Xiaoyi, Liang Chen, Sihua Liu, et al.. (2022). Impaired CD8+ T cells in term pregnancy decidua with chronic hepatitis B virus infection. American Journal of Reproductive Immunology. 88(4). e13610–e13610. 1 indexed citations
9.
Zhang, Tianling, et al.. (2021). Cytokines and Chemokines in HBV Infection. Frontiers in Molecular Biosciences. 8. 805625–805625. 47 indexed citations
10.
Liu, Xuan, et al.. (2021). Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects. Frontiers in Immunology. 12. 765101–765101. 110 indexed citations
11.
Gu, Shuqin, Chengcong Chen, Xiaoyi Li, et al.. (2021). High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection. Frontiers in Immunology. 12. 649197–649197. 5 indexed citations
12.
Li, Xiaoyi, et al.. (2020). Expanded circulating follicular dendritic cells facilitate immune responses in chronic HBV infection. Journal of Translational Medicine. 18(1). 417–417. 5 indexed citations
13.
Liao, Baolin, Zhi-Peng Liu, Linghua Li, et al.. (2020). Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. International Journal of Medical Sciences. 18(1). 29–41. 23 indexed citations
14.
Chen, Chengcong, Xiaotao Jiang, Xuan Liu, et al.. (2020). Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay. Journal of Leukocyte Biology. 109(2). 455–465. 10 indexed citations
15.
Zhang, Xiaoyong, Hui Li, Yi Wang, et al.. (2020). Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study. Virologica Sinica. 35(6). 820–829. 41 indexed citations
16.
Li, Yongyin, Libo Tang, Ling Guo, et al.. (2019). CXCL13-mediated recruitment of intrahepatic CXCR5+CD8+ T cells favors viral control in chronic HBV infection. Journal of Hepatology. 72(3). 420–430. 77 indexed citations
17.
Li, Yongyin, Libo Tang, & Jinlin Hou. (2014). Role of interleukin-21 in HBV infection: friend or foe?. Cellular and Molecular Immunology. 12(3). 303–308. 16 indexed citations
18.
Jiang, Xiaotao, Mingxia Zhang, Qintao Lai, et al.. (2011). Restored Circulating Invariant NKT Cells Are Associated with Viral Control in Patients with Chronic Hepatitis B. PLoS ONE. 6(12). e28871–e28871. 38 indexed citations
19.
Yang, Ling, Shiwu Ma, Lei Xiao, et al.. (2010). Presence of valine at position 27 of the hepatitis B virus core gene is associated with severe liver inflammation in Chinese patients. Journal of Medical Virology. 83(2). 218–224. 9 indexed citations
20.
Ma, Shiwu, Yongyin Li, Guangwen Zhang, et al.. (2010). Complementarity-Determining Region 3 Size Spectratypes of T Cell Receptor β Chains in CD8+T Cells following Antiviral Treatment of Chronic Hepatitis B. Antimicrobial Agents and Chemotherapy. 55(2). 888–894. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026